iwCAR-T 2024 Presentations & discussions (vjhemonc.com)
Scroll down to
Allogeneic CAR NK cells in adults with AML or MDS
May Daher MD Anderson Cancer Center, Houston, TX, United States
This is the center where CHM does its current AML-NK trial. This is a new research about improving NK-cell CAR-T.
Highlights some difficulties and how to overcome them. But proves that CHM's NK platform could become a huge platform for a variety of applications. If MDA researchers spent time and resources to work with NK-cells then there must be a lot to it.
Be patient guys.
GLTA
